Research progress on clinical efficacy of postoperative radiotherapy for resectable pathological stage Ⅲ A-N 2 non-small cell lung cancer / 中华放射肿瘤学杂志
Cuimeng TIAN; Baolan LI.
Chinese Journal of Radiation Oncology
; (6): 909-912, 2020.
Artículo
en Zh
| WPRIM | ID: wpr-868694
With the development of modern radiotherapy technology, the significance of postoperative radiotherapy in treating resectable stage Ⅲ A-N 2 non-small cell lung cancer has been emphasized. At present, the value of postoperative radiotherapy has been controversial due to the lack of large-size prospective randomized controlled studies. A large number of retrospective studies have confirmed that the efficacy of postoperative radiotherapy is significantly correlated with different clinicopathological characteristics. In this article, the influencing factors of the efficacy of postoperative radiotherapy were analyzed, and the subgroup of patients receiving clinical benefits was discussed, aiming to achieve precise postoperative radiotherapy.
Biblioteca responsable:
WPRO
Texto completo
Documentos relacionados